Abstract
This is the third and final issue of Progress in Pediatric Cardiology that reports results from the scientific conference on future research directions for children with idiopathic or primary cardiomyopathies that was held in Bethesda, Maryland in January 2007. The conference was sponsored by the Children's Cardiomyopathy Foundation and the National Heart, Lung and Blood Institute with additional support from the Genzyme Corporation and the Department of Pediatrics of the Leonard M. Miller School of Medicine at the University of Miami. In this issue we begin with the results from the expert roundtable discussions regarding future directions in pediatric cardiomyopathy research in the areas of genetics, epidemiology and clinical care. Topics in this issue include an update on the NHLBI funded Pediatric Cardiomyopathy Registry, stem cell therapies, signalosomes, familial dilated cardiomyopathy, cardiomyopathy related to fatty acid metabolism, peripartum and restrictive cardiomyopathy, and exercise rehabilitation and comprehensive care for children with cardiomyopathy. The editors wish to acknowledge the outstanding support of the Children's Cardiomyopathy Foundation (CCF) and its president and founder Mrs. Lisa Yue for continuing and un-
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
